Trump threatens the House Freedom Caucus on Twitter ahead of today's do-or-die health-care vote


A scheduled House vote on the Republican health-care bill was delayed Thursday evening after conservative Freedom Caucus members announced a "no" stance on the legislation following an afternoon meeting with President Trump. Losing the support of the Freedom Caucus, which believes the GOP health-care replacement is too similar to ObamaCare, ultimately left Republicans with too few votes for the bill to pass. By Thursday evening, Trump had issued a frustrated ultimatum: Either Republicans approve the American Health Care Act on Friday, or ObamaCare stays.
By Friday morning, Trump had taken to Twitter in an attempt to crank up the pressure on the mutinous Freedom Caucus:
Some observers have pointed out that Trump's attempts to coerce the Freedom Caucus could easily backfire. "I can't think of a Freedom Caucus member who would change their vote as a result of this attack," tweeted Axios reporter Jonathan Swan. "If anything would just enrage [and] solidify."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
Max Allan Collins’ 6 favorite books that feature private detectives
Feature The mystery writer recommends works by Dashiell Hammett, Raymond Chandler, and more
By The Week US Published
-
What to know about the latest Social Security cost-of-living adjustment
The Explainer The COLA for 2025 marked the smallest increase in years, and benefit recipients are not happy
By Becca Stanek, The Week US Published
-
Sen. Booker's 25-hour speech beats Thurmond
Speed Read He spoke for the longest time in recorded Senate history, protesting the Trump administration's policies
By Peter Weber, The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published